Decreased Prothrombin Activity [PE] - N0000193995
Pharmacologic Class Information
| Pharmacologic Code | N0000193995 |
| Pharmacologic Name | Decreased Prothrombin Activity |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Physiologic Effects - [PE] |
| Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Decreased Prothrombin Activity
The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Decreased Prothrombin Activity [PE].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 60687-336 | Minocycline Hydrochloride | Non-Proprietary Name: Minocycline Hydrochloride | Capsule | Oral | American Health Packaging | ACTIVE | |
| 69489-201 | Amzeeq | Non-Proprietary Name: Minocycline | Aerosol, Foam | Topical | Journey Medical Corporation | ACTIVE | |
| 70842-160 | Minocin | Non-Proprietary Name: Minocycline Hydrochloride | Injection | Intravenous | Melinta Therapeutics, Llc | ACTIVE |